Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Merck Sharp & Dohme LLC | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adolescents and their parents | Pharmacy demonstration project: HPV vaccine delivery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HPV vaccine | Drug |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Parents' willingness to get their adolescent children HPV vaccine in pharmacy | Outcome is for the national survey of parents. | At time of study |
| Parents' satisfaction with HPV vaccine vaccine administration in the pharmacy | Outcome is for demonstration study in a community pharmacy. | At time of vaccine administration |
Not provided
Not provided
NATIONAL SURVEY (probability sample)
Inclusion Criteria:
Exclusion Criteria:
● None
PHARMACY DEMONSTRATION PROJECT (convenience sample)
Inclusion Criteria:
Exclusion Criteria:
● Being the parent of an adolescent who is immunocompromised, or has other chronic illness, has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine used, or is pregnant or plan to be pregnant within a month of vaccination.
Not provided
Not provided
National survey: Parents of adolescents ages 11-18. Pharmacy sample: Parents of adolescent boys and girls, ages 11-18 whose families reside in the Chapel Hill area, and their adolescents.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Noel T Brewer, PhD | University of North Carolina, Chapel Hill | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Central Pharmacy | Durham | North Carolina | 27704 | United States | ||
| Triangle Pharmacy |
Not provided
| ID | Term |
|---|---|
| D053918 | Papillomavirus Vaccines |
| D000068857 | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 |
| ID | Term |
|---|---|
| D014765 | Viral Vaccines |
| D014612 | Vaccines |
| D001688 | Biological Products |
| D045424 | Complex Mixtures |
Not provided
Not provided
Not provided
Not provided
Not provided
N=1200 anticipated in national study N=100 anticipated in pharmacy demonstration project
| Durham |
| North Carolina |
| 27713 |
| United States |
| D017778 |
| Vaccines, Combined |